Home/SurgiMab/Françoise Cailler
FC

Françoise Cailler

CEO

SurgiMab

Therapeutic Areas

SurgiMab Pipeline

DrugIndicationPhase
SGM-101Pancreatic Ductal Adenocarcinoma (for surgical guidance)Phase II